Simvastatin — CAS 79902-63-9

Simvastatin is a semisynthetic HMG-CoA reductase inhibitor (statin) derived from lovastatin, widely prescribed for the management of hypercholesterolemia and mixed dyslipidemia. It significantly reduces LDL cholesterol and the risk of major cardiovascular events. Mediocon Inc produces pharmacopoeial-grade Simvastatin API at its GMP-certified Aurangabad facility.

• Hypercholesterolemia management
• Cardiovascular disease prevention
• LDL cholesterol reduction
• Statin formulations

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support